Skip to main
PAYS

PaySign Inc (PAYS) Stock Forecast & Price Target

PaySign Inc (PAYS) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PaySign is well-positioned for continued growth with strong second quarter results, new client wins, and a history of market share gains. With the launch of a new division for blood establishments, the company has potential for significant revenue growth. Despite potential risks, their focus on the higher-margin pharmaceutical segment puts them in a strong financial position.

Bears say

PaySign is heavily dependent on the success of their niche prepaid card programs for the healthcare industry, specifically in the plasma collection and pharma patient affordability sectors. While the company has seen strong growth in these areas, there are risks of potential competition and loss of customers, as seen with Wirecard's bankruptcy and insolvency. Additionally, the company's heavy focus on just one industry leaves them vulnerable to market changes and potential disruptions. International expansion and gaining market share in the US may provide growth opportunities, but the recent uncertainty in the industry raises concerns about the company's future prospects.

PaySign Inc (PAYS) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PaySign Inc (PAYS) Forecast

Analysts have given PaySign Inc (PAYS) a Strong Buy based on their latest research and market trends.

According to 2 analysts, PaySign Inc (PAYS) has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PaySign Inc (PAYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.